NASDAQ:SYRE | Cash Flow Statement | Spyre Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2014-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$36.2M
2026-03-31-$69.01M-$57.37M$56.58M$12.26M
2025-12-31-$62.53M-$44.58M-$247.41M$312.81M
2025-09-30-$11.18M
2025-06-30-$36.72M
2025-03-31-$44.77M-$40.99M-$61,000.00$125,000.00
2024-12-31-$56.3M$0.00-$37.2M-$170.54M$225.6M
2024-09-30-$69.03M
2024-06-30-$38.84M
2024-03-31-$43.86M$0.00-$28.54M-$104.96M$172.17M
2023-12-31-$63.18M$0.00-$31.04M$0.00-$35.27M$163.61M
2023-09-30-$40.11M
2023-06-30-$217.08M
2023-03-31-$18.42M$384,000.00-$17.63M$17.75M$10,000.00
2022-12-31-$18.82M$385,000.00-$18.14M$0.00$14M-$8,000.00
2022-09-30-$18.23M
2022-06-30-$22.32M
2022-03-31-$24.44M$403,000.00-$26.26M$37,000.00$25.76M$12,000.00
2021-12-31-$20.45M$411,000.00-$19.27M$0.00$9.66M$80,000.00
2021-09-30-$20.31M
2021-06-30-$6.83M
2021-03-31-$18.22M$355,000.00-$19.53M$450,000.00$9.3M$362,000.00
2020-12-31-$22.71M$369,000.00-$17.13M$1M$28.62M$24.68M
2020-09-30-$18.03M
2020-06-30-$21.42M
2020-03-31-$18.73M$154,000.00-$21.69M$1.39M$14.75M$282,000.00
2019-12-31-$21.5M$106,000.00-$16.29M$1.17M$10.33M$676,000.00
2019-09-30-$21.57M
2019-06-30-$18.02M
2019-03-31-$17.17M$100,000.00-$15.81M$118,000.00$13.94M$65.06M
2018-12-31-$14.9M$72,000.00-$7.2M$203,000.00-$2.13M$17.26M
2018-09-30-$11.92M
2018-06-30-$9.41M
2018-03-31-$8.12M$70,000.00-$7.45M$83,000.00$4.7M$688,000.00
2017-12-31-$6.48M$66,000.00-$5.87M$191,000.00$4.84M$684,000.00
2017-09-30-$7.87M
2017-06-30-$6.63M
2017-03-31-$6.25M$52,000.00-$5.43M$271,000.00
2016-12-31-$5.48M$36,000.00-$4.36M$121,000.00
2016-09-30-$6.24M
2016-06-30-$5.43M
2016-03-31-$4.55M$29,000.00-$3.99M$2,000.00
2015-12-31-$3.99M$29,000.00-$833,000.00$40,000.00
2015-09-30-$3.41M
2015-06-30-$1.43M
2015-03-31-$2.47M$17,000.00-$2.48M$10,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$155.2M$0.00-$169.25M-$143.48M$309.03M
2024-12-31-$208.02M$0.00-$157.41M$0.00-$353.29M$410.91M
2023-12-31-$338.79M$744,000.00-$99.91M$0.00-$108.39M$361.08M
2022-12-31-$83.82M$1.57M-$80.14M$38,000.00$57.01M$42.68M
2021-12-31-$65.8M$1.58M-$53.72M$573,000.00-$22.62M$1.39M
2020-12-31-$80.89M$996,000.00-$75.78M$4.28M-$7.6M$154.51M
2019-12-31-$78.25M$418,000.00-$65.69M$1.49M-$1.74M$65.72M
2018-12-31-$44.35M$293,000.00-$32.19M$422,000.00-$15.23M$57.07M
2017-12-31-$27.24M$249,000.00-$24.62M$619,000.00-$22.53M$12.21M
2016-12-31-$21.7M$132,000.00-$18.84M$212,000.00-$12.08M$49.37M
2015-12-31-$11.3M$89,000.00-$10.98M$208,000.00
2014-12-31-$10.35M$19,000.00-$7.34M$181,000.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.